Larvol Delta - Attune-Pharmaceuticals-Announces-Positive-Phase-1-Results160for-ATN249-an-Oral-Plasma-Kallikrein-Inhibitor-for-the-Treatment-of-HAE

ATN-249 - Attune Pharma

http://globenewswire.com/news-release/2019/01/22/1703374/0/en/Attune-Pharmaceuticals-Announces-Positive-Phase-1-Results-for-ATN-249-an-Oral-Plasma-Kallikrein-Inhibitor-for-the-Treatment-of-HAE.html

Jan 22, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev